MARKET

SAVA

SAVA

Cassava Sciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.110
+0.070
+1.73%
After Hours: 4.180 +0.07 +1.70% 16:50 03/31 EDT
OPEN
3.950
PREV CLOSE
4.040
HIGH
4.200
LOW
3.880
VOLUME
491.59K
TURNOVER
--
52 WEEK HIGH
10.95
52 WEEK LOW
1.000
MARKET CAP
101.64M
P/E (TTM)
-18.6141
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SAVA stock price target is 9.00 with a high estimate of 12.00 and a low estimate of 6.00.

EPS

SAVA News

More
  • Cassava Sciences files for $200M mixed shelf
  • seekingalpha · 3d ago
  • Cassava Sciences EPS beats by $0.05
  • seekingalpha · 5d ago
  • Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
  • GlobeNewswire · 5d ago
  • Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimers Disease
  • GlobeNewswire · 6d ago

Industry

Biotechnology & Medical Research
-0.49%
Pharmaceuticals & Medical Research
-0.25%

Hot Stocks

Symbol
Price
%Change

About SAVA

Cassava Sciences, Inc., formerly Pain Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing drug for the treatment of nervous system disorders. The Company is ocused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer’s. Its drug candidate, PTI-125, is a small molecule that targets an altered form of a scaffolding protein called filamin A (FLNA). The Company is also developing an experimental biomarker/diagnostic, PTI-125Dx. It is developing PTI-125Dx to detect Alzheimer’s disease with a blood test.
More

Webull offers kinds of Cassava Sciences Inc stock information, including NASDAQ:SAVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVA stock news, and many more online research tools to help you make informed decisions.